Explore every episode of the podcast Peer2Peer: The Podcast

Host Dr Ben LaHood welcomes Mr Allon Barsam and Ms Purvi Thomson from OCL Vision in London to discuss their first clinical experiences with the new RayOne Galaxy spiral IOL. They delve into the innovative science and technology behind the lens, which provides a full range of vision with minimal dysphotopsia. They also share insights from their first implantations and discuss the promising early results.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Professor Graham Barrett is joined by Professor Dan Reinstein and Mr Darshak Patel to discuss the benefits of RayOne EMV for post corneal refractive surgery patients.  They dive into how to match the right IOL to the patient’s corneal profile, and specifically spherical aberration, while stressing the need for comprehensive testing on patients before surgery.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries. © 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Professor Graham Barrett is joined by Professor Dan Reinstein and Mr Darshak Patel to discuss the benefits of RayOne EMV for post corneal refractive surgery patients, focusing on the importance of tailored approaches through careful diagnostics and lens selection to reduce the risk of post-operative complications.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

At AUSCRS 2024, Dr Ben LaHood led a live podcast featuring Professor Paul Ursell, Dr Josefina Botta, and Mr Luke Anderson to explore the diverse advantages of the RayPRO tool for surgeons. Tune in to this 10-minute discussion to hear each surgeon’s unique perspective on its benefits.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Join Dr. Ben LaHood and Dr. Blake Williamson as they delve into RayOne EMV and its successful integration into Dr. Williamson's US practice. Learn why Dr. Williamson chooses this lens, how it enhances patient satisfaction, and the innovative billing strategies he employs. Whether you're a US surgeon looking to optimize your financial strategy or interested in modern patient care solutions, this episode provides valuable insights into the benefits and outcomes of using RayOne EMV. Discover how this lens stands out in a busy practice and why it's a strong choice for today's patients.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

What factors drive a surgeon to switch to a different phaco system? Is it about customising settings to match your preferences, ensuring seamless integration with your operating team, or optimising efficiency? Following Rayner's recent acquisition of Sophi, Dr Ben LaHood delves into these questions with Dr Erik Mertens, who has been using the Sophi Phaco System for four years. In this insightful conversation, Dr Mertens shares his experiences and highlights the innovative features of the Sophi system that are inspiring surgeons worldwide to make the switch.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries. © 2024 Rayner Group, all rights reserved. Rayner and Sophi are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Dr Ben LaHood and Dr Rajen Desai discuss the complexities of selecting the right IOL for patients with glaucoma. They emphasise the need for a personalised approach to IOL selection while taking into consideration a multitude of factors, such a disease severity, patient lifestyles, and pupil size.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

In January 2024, Rayner, a global leader in ophthalmic solutions, acquired THIS AG, the innovative Swiss manufacturer of the Sophi phacoemulsification machine. In this episode, Prof Paul Ursell, president of UKISCRS in the United Kingdom, engages in an exclusive interview with the CEO of Rayner, and the Vice President of R&D for Sophi and Managing Director of This AG, to explore the details of the acquisition and discuss the future of this collaboration.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner and Sophi are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Hosted by Dr Ben LaHood, this special episode is in collaboration with Ophthalpreneurs and brings together the founder Amanda Cardwell Carones, alongside Mr Allon Barsam for an insightful discussion, sharing valuable insights on the crucial importance of enhancing patient counselling. Topics cover: mastering pre-surgery counselling, breaking communication barriers, and providing personalised care to achieve optimal outcomes in cataract and refractive surgery.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

In this episode of ‘Peer2Peer: The Podcast’, Dr. Eric Donnenfeld and Dr. John Hovanesian discuss a recent clinical study evaluating clinical efficacy and patient preference for a dropless treatment regimen following cataract surgery, as well as other innovative dropless solutions.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.

Rayner, the Rayner logo, OMIDRIA®, and the OMIDRIA logo are proprietary marks of Rayner. © 2024 Rayner Group, all rights reserved. US-OM-2300050 01/24

IMPORTANT SAFETY INFORMATION  OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

En este episodio especial de Peer2Peer: Podcast, grabado durante la 38º edición del Congreso SECOIR en España, el Dr. Mariano Royo, jefe del servicio de oftalmología del Hospital San Rafael y Ángel Jiménez, director de optometría, presentan el concepto de oftalmometría y discuten su importancia para la cirugía refractiva.

Este podcast se ofrece únicamente con fines de información general. Las opiniones de los presentadores son exclusivamente suyas. Nada de lo contenido en este podcast pretende ofrecer consejo médico para el tratamiento de ninguna enfermedad o dolencia, ni sustituir el consejo, diagnóstico o tratamiento médico profesional. Nada de lo presentado en este podcast tiene por objeto dar instrucciones u orientación sobre el uso de cualquier producto Rayner; no pretende reemplazar el juicio independiente de un cirujano sobre la idoneidad o los riesgos de un procedimiento para un paciente determinado. Rayner no respalda la utilización de productos para un uso distinto del indicado en sus instrucciones. Los usuarios deben consultar el etiquetado del producto y las instrucciones de uso de los productos Rayner en todos los casos. No todos los productos Rayner están disponibles en todos los países.

© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

En este episodio especial de Peer2Peer: Podcast, un panel de cirujanos del reconocido grupo oftalmológico Baviera se reúne en la 38º edición del Congreso SECOIR en España para compartir su experiencia en el día a día en consulta y quirófano y discutir sobre las últimas tendencias en oftalmología.

Este podcast se ofrece únicamente con fines de información general. Las opiniones de los presentadores son exclusivamente suyas. Nada de lo contenido en este podcast pretende ofrecer consejo médico para el tratamiento de ninguna enfermedad o dolencia, ni sustituir el consejo, diagnóstico o tratamiento médico profesional. Nada de lo presentado en este podcast tiene por objeto dar instrucciones u orientación sobre el uso de cualquier producto Rayner; no pretende reemplazar el juicio independiente de un cirujano sobre la idoneidad o los riesgos de un procedimiento para un paciente determinado. Rayner no respalda la utilización de productos para un uso distinto del indicado en sus instrucciones. Los usuarios deben consultar el etiquetado del producto y las instrucciones de uso de los productos Rayner en todos los casos. No todos los productos Rayner están disponibles en todos los países.

© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Dr Ben LaHood and Dr Cyres Mehta analyse patient lifestyles, occupations and personality types to tailor their IOL selection.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Dr. Paul Singh is joined by Dr. Arjan Hura and Dr. Karolinne Rocha at AECOS 2023 in Deer Valley to discuss why they are adopting OMIDRIA. They touch a multitude of topics including the importance of maintaining pupil stability, accessibility to the medication, patient selection, and patient experience.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.

Rayner, the Rayner logo, OMIDRIA, and the OMIDRIA logo are proprietary marks of Rayner. © 2023 Rayner Group, all rights reserved. US-OM-2300041 11/23

IMPORTANT SAFETY INFORMATION  OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

Dr Neo Tapela and Dr Mor Dickman dive into the critical importance of patient reported outcomes and the technologies that foster them to the ophthalmic industry.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Dr. Eric Rosenberg and Dr. Roger Zaldivar explore how surgeons can enhance their surgical techniques by integrating technology into their practices.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Dr Rosenberg & Dr Wiley unveil the unexplored: ophthalmologists are just scratching the surface with digital advancements.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

In this episode, we’re looking back at the 2023 Rayner Symposium at the European Society of Cataract and Refractive Surgeons in Vienna with Professor Graham Barrett, Dr Damien Gatinel, Professor Oliver Findl and Mr Allon Barsam as they discuss Balancing Quantity and Quality of Vision with Advanced Technology IOLs.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

This episode features a series of presentations and insightful discussions that took place at the 2023 Australian Society of Cataract and Refractive Surgeons Congress about EMV and EMV Toric. Join leading ophthalmologists Prof Graham Barrett, Dr Filomena Ribeiro, Dr Karl Stonecipher, Dr Damien Gatinel, Dr Georgia Cleary, Dr Dean Corbett, and Dr Brian Harrisberg as they discuss patient counseling and outcomes and more.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Rayner’s Vice President of Marketing, Chris Willis, is joined by his colleagues European Marketing Director, Tim Brown, and Medical Communications Manager, Anne Nestor, for this special episode of Peer2Peer: the Podcast. In a break from the usual surgeon-led programming they discuss Rayner’s plans for the upcoming ESCRS 2023 congress in Vienna including an expansive scientific program, two new and exciting digital launches, and more.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Recorded at AECOS, Dr Paul Singh, Dr Arjan Hura and Dr Karolinne Rocha delve into the recent advancements in ophthalmic technology. Their conversation covers the application of RayOne EMV for enhanced monovision, the importance of tracking patient-reported outcomes using RayPRO, and the role of HASA OPTIX premium, single-use instruments in promoting efficiency within the operating room.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

In the last episode of ‘Peer2Peer: The Podcast’, OMIDRIA®(phenylephrine and ketorolac intraocular solution) 1%/0.3% series, the host, Dr Arjan Hura, shares a conversation with Dr. William Wiley from the Cleveland Eye Clinic about implementing OMIDRIA into clinical practice. The discussion dives into their early initial experiences with OMIDRIA through to today where it is employed in all of their cataract procedures.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.

Rayner, the Rayner logo, OMIDRIA, and the OMIDRIA logo are proprietary marks of Rayner. © 2023 Rayner Group, all rights reserved. US-OM-2300033 07/23

IMPORTANT SAFETY INFORMATION 

OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

This episode of ‘Peer2Peer: The Podcast’, focuses on clinical performance and results from studies conducted with OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1%/0.3%.  in cataract surgery. The episode, featuring Dr. Denise Visco and Dr. Steven Silverstein, highlights the potential advantages of OMIDRIA in cataract surgery shown by rigorous clinical trials, including improved patient compliance and reduced reliance on pain medications, without increasing the risk of complications.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner or other  products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.

Rayner, the Rayner logo, OMIDRIA, and the OMIDRIA logo are proprietary marks of Rayner. © 2023 Rayner Group, all rights reserved. US-OM-2300032 07/23

IMPORTANT SAFETY INFORMATION 

OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA.

In this second episode of ‘Peer2Peer: The Podcast’ focused on OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1%/0.3, host Dr Arjan Hura, discusses the use of OMIDRIA with Dr. Cathleen McCabe and Dr. Neda Shamie. They highlight the challenges faced by surgeons who suffer from high workloads and how OMIDRIA can help mitigate some of the risks associated with stress in case of complications. Additionally, they explain the benefits of using OMIDRIA with high-risk patients, and the reasons why they often apply it in less complicated cases as well.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.

Rayner, the Rayner logo, OMIDRIA, and the OMIDRIA logo are proprietary marks of Rayner. © 2023 Rayner Group, all rights reserved. US-OM-2300031 07/23

IMPORTANT SAFETY INFORMATION 

OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA: https://www.omidriahcp.com/documents/8/OMIDRIA-Prescribing-Information.pdf

This episode of ‘Peer2Peer: The Podcast’ is the first from a series of four episodes dedicated to OMIDRIA®(phenylephrine and ketorolac intraocular solution) 1%/0.3%. Dr Arjan Hura, together with top surgeons Gary Foster, Rebecca Metzinger, Denise Visco, Neda Nikpoor, Inder Paul Singh, Kendall Donaldson, Keith Walter and Mitch Jackson share their thoughts and experience on the use of OMIDRIA in cataract surgery. They highlight the benefits of incorporating OMIDRIA, including an improved surgeon, practice, and patient perioperative experience.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner or other products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.

Rayner, the Rayner logo, OMIDRIA, and the OMIDRIA logo are proprietary marks of Rayner. © 2023 Rayner Group, all rights reserved. US-OM-2300030 07/23

IMPORTANT SAFETY INFORMATION 

OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.

Please see the Full Prescribing Information for OMIDRIA: https://www.omidriahcp.com/documents/8/OMIDRIA-Prescribing-Information.pdf

Recorded at ASCRS, Professor Oliver Findl and Prof David Chang discuss their collective dedication to promoting sustainability in the field of ophthalmology. They delve into the various initiatives, best practices, and offer a visionary outlook, ultimately illuminating the path toward a future where sustainable eye surgery thrives.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner is a proprietary mark of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Recorded at ASCRS, Dr Ben LaHood chats with Professor Graham Barrett who has made an extensive contribution to ophthalmology including Rayner’s RayOne EMV enhanced monofocal IOL.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Recorded at ASCRS, Dr Ben LaHood and Dr Damien Gatinel dive deeply into advanced IOL optics and discuss the bench testing Gatinel has performed across a large number of the IOLs currently on the market. The results of this work empower ophthalmic surgeons to better predict the performance of different IOLs based on key factors such as asphericity, aspheric aberration (positive or negative), thickness, multifocality, aperture effect, lens placement and more.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Dr Ben LaHood and Ms Lucia Pelosini discuss the effective strategies for managing astigmatism. They delve into key aspects such as patient assessment, selection processes, and the treatment of astigmatism in regular and irregular eyes. They also analyse the latest data on the RayOne EMV Toric and share invaluable insights to help achieve optimal outcomes with toric IOLs.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Mr Alastair Stuart and Dr Ben LaHood explore the advancements in technology that enable modified monovision. The discussion encompasses the utilisation of positive and negative spherical aberration, a comprehensive comparison between enhanced monofocal and trifocal IOLs, and valuable insights for surgeons striving to deliver optimal blended vision to patients who desire reduced reliance on eyeglasses. 

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Mr Alastair Stuart and Dr Ben LaHood explore the advancements in technology that enable modified monovision. The discussion encompasses the utilisation of positive and negative spherical aberration, a comprehensive comparison between enhanced monofocal and trifocal IOLs, and valuable insights for surgeons striving to deliver optimal blended vision to patients who desire reduced reliance on eyeglasses. 

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

In this episode, Rayner’s Vice President of Marketing, Chris Willis, is joined by Marketing Director for the Americas, Sam van Roon, and Sr. Director and OMIDRIA Brand Lead, Nicolee Schulze to discuss what listeners can expect from Rayner at ASCRS this year, including the US launch of HASA OPTIX and RayPRO+, and new outcome data on Rayner products that will be presented on the podium.

This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.

© 2023 Rayner Group, all rights reserved. Rayner, RayOne, RayPRO and OMIDRIA are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Dr Michael Endl reflects on his extensive experience with RayOne EMV. Having successfully implanted RayOne EMV in nearly 100 eyes, Dr Endl notes that the lens has granted patients a wide range of independence from wearing spectacles, encompassing near, intermediate, and distance vision.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

In this episode of Peer2Peer: The Podcast, Mr Allon Barsam discusses the important role that surgical instruments play in the success of eye surgery with Dr Eric Donnenfeld and Eric T'Scharner; and learns about a new player in the instrument world, HASA Optix, that believes surgeons shouldn’t have to compromise with current solutions, and has its sights on reducing the impact of eye surgery on the environment.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

In this episode of Peer2Peer: The Podcast, Mr Allon Barsam discusses the important role that surgical instruments play in the success of eye surgery with Dr Eric Donnenfeld and Eric T'Scharner; and learns about a new player in the instrument world, HASA Optix, that believes surgeons shouldn’t have to compromise with current solutions, and has its sights on reducing the impact of eye surgery on the environment.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

Is there really a gold standard for biometry? In this episode of Peer2Peer: The Podcast, host Professor Gerd Auffarth leads a discussion on important biometry considerations with guest and internationally renowned expert, Dr. Nino Hirnschall.

As we become more and more overwhelmed by new technologies, it can be difficult to decide which device(s) to use and more importantly, which one to trust.  Biometric measurements for IOL calculation have transformed from just basic parameters to more detailed measurements of the eye with more specific parameters. Are these new technologies fool proof? What kind of problems can still occur, even after using the newest, most advanced technology?  Listen in as Professor Auffarth and Dr. Hirnschall examine these questions and provide their tips and tricks of how to navigate through the various biometry options today.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

If you’re looking for an information-packed podcast on Toric IOLs, you’re in the right place.  In this episode of Peer2Peer: The Podcast, host Professor Gerd Auffarth and cataract surgery specialist, Professor Martin Dirisamer, explore the Dos and Don’ts of Toric IOLs.

Together, they condense what could be hours of discussion into one single podcast episode, including examining fundamental Toric IOL topics such as identifying patients, conducting proper measurements, choosing incision location, selecting a marking system, and managing IOL rotation.  They also cover Toric IOL materials and design and discuss some of the models on the market today.  Listen in now to get your fill on Toric IOLs.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

In this episode of Peer2Peer: The Podcast, Professor Gerd Auffarth (Germany) explores IOL materials with Dr. Ben LaHood (Australia).  Together, they dive into the widespread debate surrounding hydrophobic and hydrophilic lenses and discuss the advantages and disadvantages of each, including material opacification and glistenings.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

In this special episode of ‘Peer2Peer: The Podcast’, renowned surgeons Dr. Roger Zaldivar, Dr. Filomena Ribeiro and Dr. Joaquín Fernández Pérez gather at the 25th congress at FacoElche in Spain to discuss the key takeaways from Rayner’s clinical symposium on ‘Optical Quality & Patient Satisfaction’, and interesting and exciting trends covered at this year’s event.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

In this episode of Peer2Peer: The Podcast, Mr Allon Barsam discusses the importance of both pre-operative and post-operative management of dry eye disease with Purvi Thomson (Lead Optometrist, OCL Vision) and Caoimhe McGovern (Specialist Optometrist, OCL Vision) – the impact it can have on biometry, visual outcomes and ultimately patient satisfaction.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

As we spend ever increasing amounts of our day online, it’s safe to say that digital marketing plays an important role in educating patients and helping them to choose the right eye surgeon or clinic. In this episode of Peer2Peer: The Podcast, Mr Allon Barsam discusses the important role that digital marketing and social media play in running a busy eye clinic, with his colleagues from OCL Vision in the UK: Mr Ali Mearza, Mr Romesh Angunawela and Ms Masara Laginaf.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

Because the Centers for Medicare and Medicaid Services consider the RayOne EMV a non-premium lens, it means that US surgeons cannot bill patients directly for this IOL. However, Dr Eric Donnenfeld (United States) and Dr Jerry Hu (United States) still prefer to use the RayOne EMV, and have created billing packages so that they can offer it to their patients without actually charging for it; by including the RayOne EMV in a package deal, doctors are able to charge for additional services only. Listen to this episode of ‘Peer2Peer: The Podcast’ now to find out how Dr Donnenfeld and Dr Hu have successfully found a place for the RayOne EMV at their practices in the United States.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

With the huge range of intraocular lenses (IOLs) that are available, how do you really decide which ones fit into your practice? In this episode of ‘Peer2Peer: The Podcast’, host Mr Paul Rosen (UK) highlights some of the key insights from a Rayner webinar with Mr Allon Barsam (UK) and Mr Andrew Turnbull (UK) which address this question.

The panel also discuss why RayOne EMV has become their go-to lens; how RayOne EMV compares to trifocal IOLs; how to master monovision, and how to effectively manage the RayOne EMV patient pre-operative conversation. 

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

With the huge range of intraocular lenses (IOLs) that are available, how do you really decide which ones fit into your practice? In this episode of ‘Peer2Peer: The Podcast’, host Mr Paul Rosen (UK) highlights some of the key insights from a Rayner webinar with Mr Allon Barsam (UK) and Mr Andrew Turnbull (UK) which address this question.

The panel also discuss why RayOne EMV has become their go-to lens; how RayOne EMV compares to trifocal IOLs; how to master monovision, and how to effectively manage the RayOne EMV patient pre-operative conversation. 

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

In this episode of ‘Peer2Peer: The Podcast’, Dr Karl Stonecipher (United States) sits down with Professor Graham Barrett (Australia) — collaborator on Rayner’s RayOne EMV enhanced monofocal IOL — and asks him about the concept behind RayOne EMV. Professor Barrett also discusses why he chose to use positive spherical aberration to provide patients with extended depth of focus, the patient selection process, and why he thinks RayOne EMV is suitable for almost anyone.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

Join host Dr Lisa Nijm (United States) and guest speakers Dr Stefanie Schmickler (Germany) and Dr Josefina Botta (Argentina) as they explore female leadership in ophthalmology and championing women in the operating room in this episode of ‘Peer2Peer: The Podcast’. The surgeons share their leadership journeys, offer advice about growing a business, and also discuss the skill sets required for being a successful surgeon. To finish, they share their favourite Rayner products and reveal a ‘sweet and spicy’ opinion about being a leading woman in ophthalmology today.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

Join host Dr Lisa Nijm (United States) and guest speakers Dr Stefanie Schmickler (Germany) and Dr Josefina Botta (Argentina) as they explore female leadership in ophthalmology and championing women in the operating room in this episode of ‘Peer2Peer: The Podcast’. The surgeons share their leadership journeys, offer advice about growing a business, and also discuss the skill sets required for being a successful surgeon. To finish, they share their favourite Rayner products and reveal a ‘sweet and spicy’ opinion about being a leading woman in ophthalmology today.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer

In this episode of Peer2Peer: The Podcast, hosted by Rayner, host Dr Lisa Nijm (United States) and guest speaker Dr Paul Singh (United States) discuss the changing landscape of clinical education in ophthalmology. The surgeons consider how alternative media such as webinars and podcasts are becoming the preferred method of education among young ophthalmologists, and how educational platforms such as Rayner’s Peer2Peer are connecting surgeons and starting important conversations across the world.

The disclaimer for this episode is available in the show notes at rayner.com/peer2peer